Access Update- #28

A few quick things today:

* Electro-Optical Sciences (Nasdaq: MELA) shares are now below our recommended price of $5.75. For those of you who have been patient, waiting for the stock to come in like we said it would – here is your opportunity to buy it.

If you do not yet own the shares, BUY MELA with a $5.75 limit. As a measure of risk control, we are not recommending existing shareholders double up at this time. We still are very confident that the company’s phase III trial will be a success and MelaFind will be approved. However, we must employ sound money management and control our risk. If the device is approved, there will be plenty of giddy-up left in this horse.

* Additionally, there was a big article in the Wall Street Journal today on stem-cell usage in breast augmentation. Naturally, Cytori Therapeutics (Nasdaq: CYTX) was mentioned. Click here for the story.

* Our target date for our next report is Monday, August 25th. Keep your eyes glued to your inbox Monday morning.

That’s it for now.

Marc Lichtenfeld
Director of Research
Access Research Group

Stock
Symbol
Current Price
Comments

ViroPharma

VPHM

$13.50

Buy up to $12.50

Cytori Therapeutics

CYTX

$6.79

Buy up to $8

Electro-Optical Sciences

MELA

$5.70

Buy up to $5.75